3051 - 3060 of 8808 Results
Title
Year
-
OPENTitle: Are Clinical Certainty Ratings Helpful in the Diagnosis of Parkinson's Disease?Journal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 5Issue #: 2Start Page: 165End Page: 170Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12589Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12589Citation Count: 1
-
OPENTitle: Association between different diabetes medication classes and risk of Parkinson's disease in people with diabetesJournal Name: Pharmacoepidemiology and Drug SafetyPublisher: WileyVol: 31Issue #: 8Start Page: 875End Page: 882Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/pds.5448Best OA location URL: https://doi.org/10.1002/pds.5448Citation Count: 14
-
RESTRICTEDTitle: Enteric alpha-synuclein pathology in LRRK2-G2019S Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 40Issue #:Start Page: 83End Page: 84Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.05.001Citation Count: 7
-
OPENTitle: Cortical complexity alterations in motor subtypes of Parkinson's disease: A surface‐based morphometry analysis of fractal dimensionJournal Name: European Journal of NeurosciencePublisher: WileyVol: 60Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ejn.16612Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ejn.16612Citation Count: 0
-
RESTRICTEDTitle: Serotonergic and dopaminergic mechanisms in graft-induced dyskinesia in a rat model of Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 47Issue #: 3Start Page: 393End Page: 406Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2012.03.038Best OA location URL: https://doaj.org/article/1e207e4e620e4951aa04424fd03c5cffCitation Count: 41
-
OPENTitle: Parkinson’s Patients’ Tolerance for Risk and Willingness to Wait for Potential Benefits of Novel Neurostimulation Devices: A Patient-Centered Threshold Technique StudyJournal Name: MDM Policy & PracticePublisher: SAGE PublicationsVol: 6Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/2381468320978407Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/2381468320978407Citation Count: 22
-
OPENTitle: l‐3,4‐dihydroxyphenylalanine (l‐DOPA) modulates brain iron, dopaminergic neurodegeneration and motor dysfunction in iron overload and mutant alpha‐synuclein mouse models of Parkinson's diseaseJournal Name: Journal of NeurochemistryPublisher: WileyVol: 150Issue #: 1Start Page: 88End Page: 106Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jnc.14676Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.14676Citation Count: 33
-
OPENTitle: Holmes Tremor‐Like Phenotype in DYT1 DystoniaJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 5Issue #: 2Start Page: 206End Page: 208Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12585Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12585Citation Count: 3
- Lack of independent mood-enhancing effect for dopaminergic medications in early Parkinson's disease2019OPENTitle: Lack of independent mood-enhancing effect for dopaminergic medications in early Parkinson's diseaseJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 402Issue #:Start Page: 81End Page: 85Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2019.05.009Best OA location URL: https://zenodo.org/record/3873416Citation Count: 6
- Soluble CD163 Changes Indicate Monocyte Association With Cognitive Deficits in Parkinson's Disease2020OPENTitle: Soluble CD163 Changes Indicate Monocyte Association With Cognitive Deficits in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 4Start Page: 963End Page: 976Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28424Best OA location URL: https://pub.dzne.de/record/157801Citation Count: 51